(Q41502776)

1 October 2017

1 reference

title

Prevention of infections in bone marrow transplant recipients (English)

1 reference

1 October 2017

1

1 reference

1 October 2017

Shea TC

2

1 reference

1 October 2017

publication date

1 June 1997

1 reference

Infectious Disease Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

11

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

459-477

1 reference

Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Measurement of bacterial and fungal air counts in two bone marrow transplant units

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Factors influencing detection of quantitative cytomegalovirus antigenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Herpes simplex virus infection in the immunocompromised cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Prophylaxis of bacterial infections after bone marrow transplantation. A randomized prospective study comparing oral broad-spectrum nonabsorbable antibiotics (vancomycin-tobramycin-colistin) to absorbable antibiotics (ofloxacin-amoxicillin).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Bone marrow transplantation in thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Antimicrobial prophylaxis in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Bone marrow transplantation in childhood leukemia using reverse isolation techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Aspergillus antigen detection in the diagnosis of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

The prophylactic use of low-dose amphotericin B in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

The role of bone marrow transplantation in the management of advanced local disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970365-2

7 January 2021

10.1016/S0891-5520(05)70365-2

Identifiers

DOI

1 reference

1 October 2017

1 reference